Paliperidone Double-Layered Osmotic Pump Tablet Design
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current paliperidone osmotic pump controlled release tablets face challenges with complex preparation processes, high production costs, poor thermal stability of excipients, and significant fluctuations in drug release rates, leading to adverse reactions and reduced efficacy.
Innovation Solution
A double-layered osmotic pump controlled release tablet design featuring a moisture-permeable rigid membrane shell, a push layer, a drug layer, an isolation layer, and an aesthetic coating layer, utilizing semi-permeable polymers and hydrophilic carriers to achieve a controlled release profile with an increasing initial release rate followed by a constant rate, improving thermal stability and reducing production complexity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a traditional osmotic pump controlled release tablet is used, then controlled drug release is achieved, but the preparation process becomes complex and production cost increases
Solution Approach 1:
The tablet core is divided into two distinct layers: a drug layer containing paliperidone and hydrophilic carrier, and a push layer containing osmotic agent and expansion material. This segmentation simplifies the preparation process while maintaining controlled release functionality, as each layer has a specific role in the osmotic pump mechanism.
Solution Approach 2:
The semi-permeable membrane shell serves multiple functions simultaneously: it acts as a barrier to control osmotic water influx, provides structural integrity to the tablet, and facilitates controlled drug release through its semi-permeable properties. This multi-functionality reduces the need for additional components.
2Strength
If traditional excipients are used in osmotic pump tablets, then tablet structure is maintained, but thermal stability deteriorates
Solution Approach 1:
The patent specifies precise compositional parameters for the hydrophilic carrier (60-90 wt% of drug layer) and osmotic agent (20-40 wt% of push layer) to optimize both structural integrity and thermal stability. By controlling the concentration and type of materials, the tablet maintains its structure while improving resistance to thermal degradation during storage and processing.
3Device complexity
If conventional release profiles are used, then simple formulation is maintained, but drug concentration fluctuation increases leading to adverse reactions
Solution Approach 1:
The osmotic pump mechanism creates a dynamic release profile where the push layer progressively expands as it absorbs osmotic water, continuously pushing the drug layer through the semi-permeable membrane. This dynamic process ensures a steady, controlled release rate that maintains stable plasma drug concentrations and eliminates the peak-trough fluctuations associated with conventional formulations.
4Reliability
If multi-layered osmotic pump tablet is designed, then drug release control is improved, but production cost increases
Solution Approach 1:
The patent combines the drug delivery function and the osmotic pump mechanism into a single integrated tablet structure with two layers. The drug layer and push layer are formulated to work together synergistically, eliminating the need for separate pumping mechanisms or additional release-controlling components, thereby reducing manufacturing complexity and cost.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new formulation simplifies production, enhances thermal stability, maintains stable plasma concentrations, reduces adverse reactions, and improves the safety and compliance of paliperidone administration for treating schizophrenia and bipolar mania.
Implementation Method 1
a moisture-permeable rigid membrane shell having one or more drug-release orifices at one end, which is made of a controlled release layer composition comprising a semi-permeable polymer
Implementation Method 2
A double-layered osmotic pump controlled release tablet design featuring a moisture-permeable rigid membrane shell, a push layer, a drug layer
Implementation Method 3
a drug layer inside the rigid membrane shell, adjacent to the release orifices and directly contacting with the push layer, which is made of a drug layer composition comprising a pharmaceutically active ingredient, one or more kinds of hydrophilic polymer carriers
Implementation Method 4
a push layer inside the rigid membrane shell and away from the side of the release orifices, which is made of a push layer composition comprising a expansion material, an osmotic agent
Data Source
AI summary
A paliperidone double-layered osmotic pump controlled release tablet and the preparation method thereof are disclosed. The double-layered osmotic pump controlled release tablet comprises a rigid membrane, a push layer, a drug layer, an isolation layer and an aesthetic coating, wherein the rigid membrane contains a semi-permeable polymer, a porogen and/or a plasticizer and has one or more drug release orifices on one end, the push layer comprises an expanding material, an osmotic agent, a binder, a colorant and a lubricant, the drug layer contains a pharmaceutically active ingredient, a hydrophilic polymer, an osmotic agent, a colorant, a lubricant and an antistatic agent, the isolation layer is located between the inner surface of the rigid membrane and the push layer, and contains a hydrophilic polymer. The paliperidone double-layered osmotic pump controlled release tablet shows an increasing drug release rate at early stage and keeps a constant drug release rate at later stage.